Blood Eosinophil Count, Smoking Status Predict ICS Response in COPD
Assessment of patient blood eosinophil count and smoking status may help optimize treatment with inhaled corticosteroids (ICS), a post-hoc analysis of the pivotal IMPACT trial noted.Prospective modeling of blood eosinophil count as a continuous measure, rather than a single cut-off eosinophil threshold, showed greater response to ICS in terms of exacerbation reduction with increasingly greater blood eosinophil count in patients with moderate-to-severe COPD with at least one exa
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies